<DOC>
	<DOCNO>NCT00993304</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate whether new compound , liraglutide , reduces level lipid ( fat ) , include cholesterol , blood type 2 diabetic , follow meal high fat content .</brief_summary>
	<brief_title>A Trial Assess Effect Liraglutide Blood Triglyceride ( Fat ) Levels After Meal Type 2 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Subjects type 2 diabetes mellitus ( diet exercise treat , treat specific oral antidiabetic ( metformin , sulfonylureas glinides ) mono combination therapy ) diagnose least 3 month previously BMI 18.5 40 kg/m2 HbA1c 6.5 10.0 % inclusive Known suspect allergy trial product relate product Previous participation trial ( randomise ) . Rescreening screen failure allow Females childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method ( adequate contraceptive define combination oral contraceptive ( OC ) , hormonal intra uterine device ( IUDs ) , implant injectables ; Germany , condom male partner must use combination OC , IUD , implant injectables duration trial 30 day follow last dose trial medication ) sterile postmenopausal The receipt investigational drug within 3 month prior trial Previous insulin treatment ( shortterm insulin treatment 7 day exempt occur later 3 month prior screen ) . Cancer ( except basal cell skin cancer squamous cell skin cancer ) clinically significant disorder ( except type 2 diabetes ) Clinically significant active cardiovascular disease include history myocardial infarction ( heart attack ) within past 6 month and/or heart failure discretion Investigator . History alcoholism drug abuse last 12 month Blood donation within last 3 month . Plasma donation within last month . Additional exclusion criterion Germany : Male subject sexually active partner could pregnant , use barrier method contraception ( e.g . condom ) duration trial 30 day follow last dose trial medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>